Skip to ContentSkip to Navigation
About us Faculty of Science and Engineering News

Medicine to restore alveoli

29 March 2022

Professor Reinoud Gosens of the Groningen Research Institute of Pharmacy (GRIP), together with an international team of top researchers, is working on an answer to the question: why do the alveoli in people with COPD not recover? The research by Gosens and his team is called 'On a voyage of discovery to the dark side of the lung'. If this side of the lung reveals that secret, the dream of countless people with a lung disease comes closer: permanent lung recovery and no more shortness of breath.

Reinoud Gosens
Reinoud Gosens

Progenitor cells are found in the lungs. These are cells that resemble stem cells. Together with other lung cells, they ensure the recovery of lung tissue after damage. In people with COPD, the growth factors that stimulate the progenitor cells to repair are not doing well enough. That is why it is important that new drugs are introduced that ensure that the lung tissue recovers.

Reinoud Gosens and his team studied how the genes in the lungs of people with COPD behave. This allowed them to look for possible medicines, which they then tested on a 'mini-lung'. Read the full news item and about the research results on the Longfonds (Lung fund) website.

Last modified:29 March 2022 1.45 p.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 17 July 2025

    Veni-grants for eleven UG researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...

  • 14 July 2025

    ERC Proof of Concept grant for Kottapalli and Covi

    Professors Ajay Kottapalli and Erika Covi have received Proof of Concept grants from the European Research Council (ERC).

  • 10 July 2025

    Dutch Research Agenda funding for nanomedicine research

    Prof Dr Anna Salvati, Dr Christoffer Åberg and Prof Dr Siewert-Jan Marrink have been granted a National Science Agenda (NWA) funding to further develop life-saving drugs based on nanotechnology with the NanoMedNL consortium.